RUNX1 and acute myeloid leukemia: However, patients with this translocation show similarities to AML with RUNX1::RUNX1T1 with regard to morphology, immunophenotype, gene expression profiling, and response to therapy with a relatively good prognosis (with 70–80% of patients achieving complete remission) [21].